A comprehensive approach to benefit-risk assessment in drug development.
Sarac SB, Rasmussen CH, Rasmussen MA, Hallgreen CE, Søeborg T, Colding-Jørgensen M, Christensen PK, Thirstrup S, Mosekilde E.
Sarac SB, et al. Among authors: mosekilde e.
Basic Clin Pharmacol Toxicol. 2012 Jul;111(1):65-72. doi: 10.1111/j.1742-7843.2012.00871.x. Epub 2012 Mar 17.
Basic Clin Pharmacol Toxicol. 2012.
PMID: 22356197
Free article.